Bing Li

发表

KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF

A. D. de Vos, Renhui Yang, A. Ogasawara, 2002, Hypertension.

An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteins

R. Scheller, B. Jaiswal, I. Hötzel, 2014, mAbs.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Bing Li, Napoleone Ferrara, J. Winer, 1993, Nature.

Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)

N. Ferrara, J. Lecouter, B. Moffat, 2001, The Journal of Biological Chemistry.

Molecular recognition by a binary code.

Sachdev S Sidhu, Bing Li, Andrew A Peden, 2005, Journal of molecular biology.

Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12

M. Ultsch, R. Kelley, Weiru Wang, 2013, Clinical Cancer Research.

Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies

F. Peale, L. Rangell, G. Fuh, 2007, Proceedings of the National Academy of Sciences.

Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1

Kenneth J. Hillan, Napoleone Ferrara, K. Hillan, 2003, Science.

Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.

B. Pan, W. Fairbrother, A. Cochran, 2002, Journal of molecular biology.

Vascular Endothelial Growth Factor–Induced Genes in Human Umbilical Vein Endothelial Cells: Relative Roles of KDR and Flt-1 Receptors

A. D. de Vos, P. Williams, M. Gerritsen, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity

W. Sandoval, R. Kelley, W. Phung, 2013, mAbs.

Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists.

Sachdev S Sidhu, Bing Li, S. Sidhu, 2006, Journal of molecular biology.

Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.

Frederic A. Fellouse, C. Eigenbrot, S. Sidhu, 2004, Journal of molecular biology.

Receptor-selective Variants of Human Vascular Endothelial Growth Factor

A. D. de Vos, M. Gerritsen, G. Fuh, 2000, The Journal of Biological Chemistry.

Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin

M. Ultsch, C. Eigenbrot, J. Ernst, 2016, Scientific Reports.

In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation

R. Kelley, I. Hötzel, P. Luan, 2014, mAbs.

Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge

R. Kelley, C. Eigenbrot, Y. Meng, 2014, mAbs.

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.

A. D. de Vos, H. Christinger, G. Fuh, 1999, Journal of molecular biology.

VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.

A. D. de Vos, Y. Muller, B. Cunningham, 1998, Structure.

Improving Therapeutic Efficacy of a Complement Receptor by Structure-based Affinity Maturation

M. van Lookeren Campagne, R. Kelley, L. Diehl, 2009, The Journal of Biological Chemistry.